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Abstract
Venezuelan equine encephalitis (VEE) complex alphaviruses are important re-emerging
arboviruses that cause life-threatening disease in equids during epizootics as well as spill-
over human infections. We conducted a comprehensive analysis of VEE complex alpha-
viruses by sequencing the genomes of 94 strains and performing phylogenetic analyses of
130 isolates using complete open reading frames for the nonstructural and structural poly-
proteins. Our analyses confirmed purifying selection as a major mechanism influencing the
evolution of these viruses as well as a confounding factor in molecular clock dating of ances-
tors. Times to most recent common ancestors (tMRCAs) could be robustly estimated only
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KU059756, KU059757, KC344528, KC344484,
KC344525, KC344526, KC344486, KC344487,
KC344488, KC344506, KC344523, KC344490,
KC344502, KC344503, KC344504, KC344507,
KC344508, KC344509, KC344510, KC344511,
KC344512, KC344513, KC344514, KC344517,
KC344518, KC344519, KC344520, KC344521,
for the more recently diverged subtypes; the tMRCA of the ID/IAB/IC/II and IE clades of
VEE virus (VEEV) were estimated at ca. 149–973 years ago. Evolution of the IE subtype
has been characterized by a significant evolutionary shift from the rest of the VEEV com-
plex, with an increase in structural protein substitutions that are unique to this group, possi-
bly reflecting adaptation to its unique enzootic mosquito vector Culex (Melanoconion)
taeniopus. Our inferred tree topologies suggest that VEEV is maintained primarily in situ,
with only occasional spread to neighboring countries, probably reflecting the limited mobility
of rodent hosts and mosquito vectors.
Author summary
The Venezuelan equine encephalitis (VEE) complex comprises a broadly distributed
group of alphaviruses in the Americas that have the potential to emerge and cause severe
disease. Historically, VEE complex viruses have caused recurring outbreaks of human and
equine encephalitis in Central and South America as well as Mexico, with at least one out-
break resulting in movement of the virus to the southern United States. We present the
most comprehensive phylogenetic analysis of complete genomic sequences of the most
prominent member of the VEE complex, VEE virus (VEEV). We were able to identify the
major forces influencing VEEV evolution, and using the inferred phylogenies we deter-
mined that VEEV evolves in geographically segregated lineages with enzootic transmis-
sion between rodents and mosquitoes apparently limiting its spread.
Introduction
The Venezuelan equine encephalitis (VEE) antigenic complex comprises a group of alpha-
viruses that share similar genetic characteristics and can be defined by broad cross-reactivity
antigenically [1] which defines them as a group within the Alphaviridae. The VEE complex
alphaviruses are classified into six subtypes, designated I to VI, and consist of 9 species [2], of
which subtype I contains the veterinary and medically important VEE virus (VEEV) (Table 1).
Historically, the VEE complex subtypes I-VI were defined by serological analysis, and this
nomenclature has persisted. However, the advent of sequencing resulted in several viruses
now being reclassified as distinct species. For example, subtype IF is genetically distinct from
the remainder of the subtype I viruses and is now classified as the species Mosso das Pedras
virus. Most VEE complex viruses have enzootic cycles where they circulate between wild ani-
mals, generally rodents and mosquitoes, particularly Culex (Melanoconion) spp. mosquito vec-
tors. With the exception of VEEV subtype II, VEE complex viruses are geographically
distributed throughout Central and South America. VEEV subtype II is found only in Florida
and is usually transmitted by Culex cedeci mosquitoes. The recent appearance for the first time
of Culex (Melanoconion) species in southern Florida [3] underscores the continuing threat of
emergence, possibly enhanced by climate change, which also increases the potential for other
VEEV subtypes to spread northwards and establish enzootic transmission cycles. Although
many VEE complex viruses have not been implicated in human disease, those that are associ-
ated with human disease (VEEV) can cause acute, often severe febrile illness that may progress
to encephalitis, causing severe human morbidity and mortality [4]. Patients who survive
encephalitis are often left with permanent neurologic sequelae, and the cost for treatment and
long-term care related to a single case can be several million dollars [5]. In addition to VEEV
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(subtype I), which cases the majority of the encephalitis cases within the VEE subtype, subtype
II Everglades virus (EVEV), which is found only in Florida, can cause neurologic disease
in humans [6] and equids [7]. Subtype IIIA, Mucambo virus, also causes febrile disease in
humans [8, 9].
VEEV is associated with human disease, and is further subdivided into subtypes IAB, IC,
ID, IE. Subtypes ID and IE comprise enzootic/endemic strains that circulate continuously in
forests and swamps of northern South America, Central America and Mexico and cause a
large burden of endemic disease from direct spillover [10]. The remaining VEEV subtypes,
IAB and IC, comprise epizootic/epidemic strains that are associated with periodic equine-
amplified outbreaks that result in severe disease in equids and extensive spillover to humans
[11]. These outbreaks can spread from South America as far north as the southern United
States [12, 13], resulting in up to hundreds-of-thousands of cases over a period of months to a
few years. Prior to the 1980s, VEE epizootics involving high case-fatality rates were frequently
recorded. Because horses have been an important component of the local agricultural econo-
mies within many Latin American regions, VEE has often had a sizeable economic impact as
well as a direct effect on public and veterinary health [14]. Recent outbreaks during the 1990s
in Venezuela, Colombia and Mexico have demonstrated the potential for VEEV to re-emerge
periodically from enzootic progenitors [15–18]. The emergence of VEEV into an epidemic/
epizootic form has been associated with specific mutations that arise in the VEEV envelope
glycoprotein 2 (E2) gene of enzootic subtype ID or IE strains. These mutations result in the
Table 1. The subtypes of VEE complex alphaviruses and their transmission cycles.
Virus Subtype Abbreviation First
Isolation
Geographic Range Vertebrate
Host Range
Mosquito vector Human
Disease
Endemic/
Epidemic
Venezuelan
equine
encephalitis
IAB VEEV Venezuela
1938
Trinidad, Peru,
Colombia,
Guatemala-Mexico-
Texas
Horses/
humans
Aedes and Psorophora
spp
Yes Epidemic
IC Colombia,
1962
Colombia,
Venezuela, Peru
Horses/
humans
Aedes and Psorophora
spp
Epidemic
ID Colombia,
1961
South and Central
America
Rodents Culex (Melanoconion)
spp.
Endemic
IE Panama,
1961
Central America Rodents,
horses,
humans
Culex (Melanoconion)
taeniopus and Psorophora
and Aedes spp.
Epidemic/
Endemic
Everglades II EVEV Florida,
USA, 1963
Florida Birds Culex (Melanoconion
spp.)
No Endemic
Mucambo IIIA MUCV Trinidad,
1954
South America Unknown Culex portesi yes Endemic
Tonate IIIB TONV French
Guiana,
1973
South and Central
America
Unknown Unknown No Unknown
71D1252 IIIC South America Unknown Unknown No Unknown
Pixuna IV PIXV Brazil, 1964 South America Unknown Unknown No Unknown
Cabassou V CABV French
Guiana,
1968
French Guiana Unknown Culex portesi No Unknown
Rio Negro
(AG80_663)
VI RNV Argentina,
1980
Argentina Unknown Unknown No Unknown
Mosso das
Pedras
(78V3531)
IF MDPV Brazil, 1978 Brazil Unknown Culex (Melanoconion) sp. No Unknown
https://doi.org/10.1371/journal.pntd.0005693.t001
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addition of positively charged amino acid changes on the surface of the virion spikes [19] that
give rise to increased virulence and viremia in equids [20, 21] and sometimes enhanced infec-
tion of epidemic vector mosquitoes such as Aedes (Ochlerotatus) taeniorhynchus [22]. The
higher viremia levels in equids can lead to infection of mosquitoes that are not normally
involved in enzootic circulation [23], which can then result in spillover infections of humans
and other domestic animals.
The phylogenetic characteristics of the VEE complex have been studied for several decades,
recently focusing on structural protein gene sequences [24–27]. These studies support the
hypothesis that the IAB and IC subtypes arise from mutations in enzootic ID strains that result
in the acquisition of epizootic/epidemic characteristics [19, 20, 28]. Although some studies
have addressed the evolution and continued circulation of VEEV ID and IE strains, the use of
only partial genomic sequences has limited their resolution and accuracy.
To date, insufficient complete genomic sequences have been available to permit a detailed,
global analysis of all VEE complex species/strains and obtain high-resolution phylogenetic
results. Our goal was to determine more accurately the temporal origin of the VEE complex
and patterns of historic spread. By increasing the number of sequenced VEEV strains from the
ID and IE subtypes, we sought a more robust analysis of the evolution of these subtypes. To
this end, a set of 130 complete genome sequences was prepared, of which 94 were determined
in this study, and a comprehensive phylogenetic study was performed to determine the origin
and evolutionary patterns of these important viruses.
Materials and methods
Virus isolates
Viruses were obtained from the World Reference Center for Emerging Viruses and Arbovi-
ruses and other collections at the University of Texas Medical Branch, and included 94 isolates
that had not been previously sequenced or had only partial genome sequences available. These
strains were geographically and temporally distributed across North and Central America, and
over the past 80 years. The metadata for the 94 virus strains sequenced in this study and their
accession numbers are found in S1 Table.
Virus propagation and cDNA generation
Vero (African green monkey kidney) cells (CCL-81, ATCC) were grown in 150 cm2 flasks to
~80% confluency and inoculated with VEE complex virus strains. S1 Table shows the strains
included in this study and their associated metadata. Infected cells were maintained at 37˚C
until the development of cytopathic effects. Then, cell culture supernatants were clarified at
1,125 x g for 10 min and mixed with a 1/3 volume of 4X precipitation buffer (28% PEG 8000,
9.2% NaCl). After overnight incubation at 4˚C, virus was pelleted at 2,880 x g for 30 min at
4˚C and resuspended in 250 μl of TEN buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.1 M
NaCl), which was then added to 750 μl of TRIzol LS Reagent (Invitrogen, Grand Island, NY).
RNA was extracted following the manufacturer’s protocol, then resuspended in 50 μl of H2O
and stored at -80˚C.
The SuperScript III First-Strand Synthesis System (Invitrogen, Grand Island, NY) was used
to produce cDNA following the manufacturer’s recommendations. Three 20 μl-reactions were
performed, each with 6 μl of extracted RNA and 1 μl of one of the following cDNA primers,
50 ng/μl of random hexamers, 50 μM oligo (dT)20, and 10 μM of reverse primers designed to
anneal approximately 500 nt downstream of the 5’ end of the viral genome. Samples were
treated with RNase H, and the resulting cDNA generated from random hexamers and oligo
(dT)20 primers were then mixed together. The cDNA samples were stored at -80˚C until
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further processing, and efficient reverse transcription was confirmed by PCR using 0.5 μl of
each sample and primer pairs designed to anneal near the 5’ and 3’ portions of the genome.
Sequencing of VEEV genomes
Sequences were assembled using sequence-independent single primer amplification (SISPA)
to barcode random primed cDNAs [29, 30] from individual cDNA samples. SISPA products
were normalized and pooled into a single reaction that was purified using a PCR purification
kit (Qiagen, Valencia, CA). Samples were subsequently gel purified to select for products
ranging from 300-500bp in size for sequencing with the Illumina Genome Analyzer II or 500-
800bp in size for Roche 454 Titanium (GS-FLX) sequencing [31], or were sequenced on the
Illumina HiSeq using the following protocol; cDNA (0.05–1.7 μg) was fragmented by incuba-
tion at 94˚C for eight (8) minutes in 19.5 ul of fragmentation buffer (Illumina 15016648).
Samples were tracked using the “index tags” incorporated into the adapters as defined by the
manufacturer. Cluster formation of the library DNA templates was performed using the Tru-
Seq PE Cluster Kit v3 (Illumina) and the Illumina cBot workstation using conditions recom-
mended by the manufacturer. Paired end 50 base sequencing by synthesis was performed
using TruSeq SBS kit v3 (Illumina) on an Illumina HiSeq 1500 using protocols defined by the
manufacturer.
Assembly of VEEV genomes
Next generation sequencing (NGS) reads from Roche 454 GS-FLX were sorted based on
SISPA barcode matches, trimmed, and searched by TBLASTX against a custom reference
nucleotide database of full-length VEE complex genomes downloaded from GenBank. Any
chimeric VEEV sequences or non-VEEV sequences amplified during the random hexamer-
primed amplification were removed. For each sample, the filtered GS-FLX reads were then de
novo assembled using CLC Bio’s clc_novo_assemble program. The consensus sequence of the
de novo assembly was used to identify the best full-length VEEV genome downloaded from
GenBank to use as a mapping reference sequence. Both GS-FLX and Illumina reads were then
mapped to the selected reference VEEV genome using CLC Bio’s clc_ref_assemble_long pro-
gram. At loci where both GS-FLX and Illumina sequence data agreed on a variant compared
to the reference sequence, the latter was updated to reflect the difference. A final mapping of
all sequences to the updated reference sequences was then performed, resulting in the final
assembled genome. Upon review of NGS assemblies, there were circumstances that required
the use of RT-PCR followed by Sanger capillary sequencing to fill gaps in genomic regions
with low coverage. These cases included finishing/closure tasks to increase the sequencing cov-
erage of genome regions inadequately covered by NGS.
Sequences identified with an asterisk in S1 Table were part of a different sequencing proj-
ect and were therefore analyzed using a different platform. These sequences were first sub-
jected to a blast analysis to determine the number of viral reads and the percentage of
contaminating reads from hosts, or other sources. Then the contamination reads from the
Vero cells were filtered out using the African Green Monkey (Chlorcebus sabeus) genome as
a template. The remaining Fastq files were additionally processed using trimmomatic to
remove low quality sequence. Finally, assembly was performed using iMetAMOS [32] using
the standard parameters.
Data sets
Nucleotide sequences were manually aligned with similar GenBank sequences using MUSCLE
implemented in SeaView [33]. Untranslated regions (UTRs) of alphavirus genomes show
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limited conservation and are often difficult to align reliably. Therefore, the sequences were
edited and trimmed to remove untranslated regions, resulting in concatenated ORFs for 130
(126 VEEV and 4 EEEV) sequences. Sequences were then re-aligned as protein sequences
before being reverse translated to nucleotides to maintain codon alignments. Within the
VEEV genome, there are two regions that have proved historically difficult to align, the 3’ end
of the nsP3 and the 5’ end of the capsid gene [34]. Thus these were removed from the align-
ment and the resulting alignment was used for subsequent analyses and this alignment is avail-
able upon request. Eastern equine encephalitis virus, the sister virus to VEEV in the alphavirus
genus [35], was used as an outgroup in all analyses except molecular dating and selection.
Sequences were analyzed for percent identity at the nucleotide and amino acid level using
BioEdit [36].
Phylogenetic trees
A maximum likelihood (ML) phylogeny was inferred using PAUP 4.0 [37] and the General
Time Reversible (GTR +Γ4+I) model, selected by Modeltest [38]. To assess the robustness of
tree topologies, bootstrapping was performed using 1,000 replicate neighbor-joining trees.
Bayesian phylogenetic inference was performed using the GTR +Γ4+I model in MrBayes v3.1
[39, 40]. Analyses were run for one million iterations until they reached convergence.
Estimated evolutionary rates and dates of divergence
Substitution rates and times to most recent common ancestor (tMRCAs) were estimated using
Bayesian evolutionary analysis by sampling trees (BEAST) v1.7.1 [41, 42]. BEAST employs a
Bayesian Markov chain Monte Carlo (MCMC) approach to infer demographic histories, evo-
lutionary rates and dates of divergence from serially (dated) sampled sequence data. Statistical
uncertainty in the data is reflected in the 95% highest posterior density (HPD) values. Analyses
were typically performed using the Bayesian Skyline Plot (BSP) model of population growth,
which does not use a pre-specified demographic model [43]. We used this model because the
VEE complex would not all show the same patterns of demographic change and this did not
impose constraints on the different subtypes of VEEV. To estimate substitution rate variation
among lineages we used the models implemented in the BEAST program [44] including the
uncorrelated lognormal (UCLN) model for the VEEV IE strains and the uncorrelated expo-
nential (UCEX) model for the VEEV ID/II/IAB/IC strains as these were determined to be the
most accurate model using the stepping stone algorithm implemented in BEAST [45]. The
MCMC chain was 100 million generations long, thinned to include every 5000th generation
in the final sample. The program Tracer version 1.5 (http://tree.bio.ed.ac.uk/software/tracer/)
was used to confirm convergence and mixing. The software TreeAnnotator version 1.7.1
(http://beast.bio.ed.ac.uk/software/TreeAnnotator) was used to summarize the data output
from BEAST. The maximum clade credibility (MCC) tree was estimated using mean node
heights after discarding the initial 10% of generations as burn-in.
Selection analysis
To investigate the nature of selective pressures acting on VEE complex viruses, we estimated
the average number of nonsynonymous (dN) and synonymous (dS) nucleotide substitution per
site (dN/dS ratio), using a counting method SLAC [46], as well as the numbers and locations of
sites experiencing episodic positive selection using MEME [47].
In the presence of strong purifying selection, standard models of molecular evolution (e.g.
GTR +Γ4+I) tend to underestimate branch lengths in RNA and DNA virus phylogenies [48–
50]. Therefore we re-estimated branch lengths using a Branch-Site REL (BRSEL) [51] model
Evolution of VEEV complex alphaviruses
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that accounts for variation in selection pressure across the genome and across different
branches in the phylogeny, using the HyPhy software package (50). The original formation of
the BSREL model allowed three ω (dN/dS) rate classes on each branch, each representing a pro-
portion of sites in the alignment. To prevent over-fitting, we implemented a step-up procedure
via an adaptive BSREL model (aBSREL; [52]), starting with a single dN/dS class on each branch
and testing the fit of an additional dN/dS class using small-sample corrected Akaike informa-
tion criteria (c-AIC).
Recombination analyses
All sequences were analyzed for recombination using the program RDP3 [53]. Recombination
events were determined using RDP, GENECONV, MaxChi, Chimaera and 3Seq, and were
only considered robust if they were identified using more than one method.
Results
Phylogenetic analysis of the VEE complex strains
The unrestricted Bayesian (MrBayes) and maximum likelihood trees (PAUP) inferred the
expected topology with Cabassou virus (CABV, subtype V), Rio Negro virus (RNV, subtype
VI), and Mosso das Pedras virus (MDPV, subtype IF) falling basal to the remainder of the sub-
types, as has been shown in previous analyses (Fig 1) [25, 34]. Unexpectedly, the MCC tree,
inferred using BEAST (S1 Fig) did not resolve the placement of CABV, RNV, and MDPV,
with this grouping showing low posterior support.
Mutations that were unique to each subtype or group of subtypes were identified, as well as
those synapomorphies that defined lineages within subtypes; uninformative sites were not
counted. For VEEV subtype IE, there were significantly more synapomorphic mutations in
the structural protein genes than would be expected if mutations were randomly distributed
across the genome (p<0.05, Fisher’s exact test). For all other subtypes and groups of subtypes,
the distribution of mutations was not significantly different from expected given the length of
the ORF’s. For the VEE complex subtypes III-VI, the number of mutations was identified on
each branch (See S1 Fig). There was no correlation between branch length and the number of
amino acid substitutions unique to each of these subtypes.
Correcting for the effect of purifying selection when estimating tMRCAs
and evolutionary rates
The predominance of purifying selection in alphavirus evolution has been widely reported [54,
55], and this type of selection has been postulated to bias tMRCA estimations for ancient
divergence events in RNA viruses [48, 49]. To test our hypothesis that, like other ancient RNA
viruses [48–50], dating estimates may be biased in the VEE complex due to the presence of
strong purifying selection, we employed a branch-site random effects likelihood (BSREL)
approach to determine the extent to which branch lengths (and tMRCAs) were underesti-
mated by standard models of nucleotide evolution. By moving up through the VEE complex
phylogeny in an iterative process, we removed the most basal lineages and compared total
tree length optimized under BSREL and GTR+Γ4, thereby identifying subtrees whose branch
lengths did not expand under BSREL compared with a standard nucleotide model (GTR+Γ4)
(Figs 1 & 2). We assert that it is these subtrees, which were not underestimated by GTR+Γ4,
whose tMRCA can be reliably inferred by standard Bayesian molecular clock dating (e.g.
BEAST) (Fig 2).
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As we could not generate a fully resolved MCC tree for the entire VEE complex, two trees
were generated for subtypes IAB/IC/ID and for subtypes IE. Removing the other branch
lengths removed some of the uncertainty regarding the substitution rates as well as the lack of
samples for many of the other subtypes, which can skew the data. The subtype IAB/IC/ID
VEEV strains fell into two main groups, a Panamanian lineage and a Venezuelan/Colombian
lineage. In addition, we sequenced two additional strains MAC10 and MHC88 from Venezu-
ela, which are outliers from the rest of the ID/IAB/IC strains (Fig 3). These strains showed that
VEEV has been circulating in its current form for around 253 years, although the date of this
node could not be accurately determined as determined by the BSREL analysis. In fact only
group K (Figs 1 and 3), which fell within the Colombian/Venezuelan lineage could be reliably
dated at 1934 (1904–1950) (without BSREL correction). The Venezuelan samples MAC10 and
MHC88 were basal to the rest of the strains. Within the Venezuelan/Colombian and Panama-
nian lineages, the Peruvian strains were present in both lineages and, given the shape of the
tree and the distribution of these viruses, it is most likely that they represent recent introduc-
tions. Although synapomorphic amino acids were identified for the major lineages of the ID
subtype (see S2 Fig) the distribution of the amino acid substitutions between the structural
Fig 1. Maximum likelihood phylogeny for VEEV complex. Relevant internal nodes are identified.
https://doi.org/10.1371/journal.pntd.0005693.g001
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and non-structural proteins for each lineage was not significantly different from expected
based on a random distribution across the genome.
All of the subtype IAB strains occupied a single clade (see Fig 3), with the Hoja Redonda
(1942.HojaRedonda.Peru) and Piura (1950.Piura.Peru) strains forming the most basal branch.
Previous analyses suggested that the IAB outbreaks after 1943 were caused by incompletely-
inactivated vaccines derived from early IAB isolates [27], consistent with our results. These
vaccines were used in South and Central America until the early 1970s, when the TC-83 live-
attenuated strain replaced them after its demonstrated efficacy during the 1971 Texas outbreak
and in experimental studies [56]. The mechanism of the original IAB emergence is believed to
be mutations in the E2 protein gene of enzootic ID strains [19]. Unfortunately, the ID progeni-
tor strains for this group have has not been identified.
Fig 2. Evidence of branch length underestimation in the VEE complex shown via comparison of tree lengths
inferred under Branch-Site REL (BSREL) and GTR+Γ4 substitution models. Letters correspond to nodes in maximum
likelihood tree. The aBSREL analysis performed with an optimized number of rate classes is shown in black. BSREL
analysis performed with a fixed number of three rate classes is shown in gray. Instances in which only a black letter is
shown indicate that aBSREL and BSREL produced identical results. The dashed line depicts x = y, an unbiased analysis.
https://doi.org/10.1371/journal.pntd.0005693.g002
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For the subtype IE, a separate coalescent analysis was performed (Fig 4). The BT2607 and
MenaII isolates were basal in this tree as expected given previous analyses [16]. These viruses
were isolated in the 1960s and no further strains are available from this lineage. The remaining
subtype IE strains fell into two major groups with the tMRCA of 91 (68–124) years before the
present. The Pacific Coast strains contained samples from the entire known geographic range
of VEEV subtype IE, except Panama (Guatemala, Honduras, Nicaragua and Mexico) and the
Gulf Coast strains included isolates from Mexico only, and a single strain from Belize. The
most recent VEEV strains from Mexico were found in this second group. However, the paucity
of recent isolates from Central America suggests that some of the temporal groupings in our
trees may reflect sampling bias. The Gulf Coast IE strains diverged after the Pacific Coast
strains 76 (95% HPD; 58–102) years prior to 2010, and the Pacific Coast strains diverged 85
(95% HPD; 63–116). However, only the clades designated R and T (Figs 1 & 4) could be reli-
ably dated.
Fig 3. The genetic relationships of the II/ID/IAB/IC subtypes of the VEEV complex. MCC tree as determined by coalescent analysis for
the ID/II strains with the IAB and IC strains included. All branches had posterior probabilities of >0.97 except for the branches marked with a
*, which did not have significant support. The time to most recent common ancestors (tMRCA) dates for individual branches as identified
from the MCC tree are indicated on significant branches with the highest posterior density (HPD) in brackets, dates of clades supported by
BSREL were emboldened. Subtype IAB strains are highlighted by the grey box.
https://doi.org/10.1371/journal.pntd.0005693.g003
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Recombination analysis
There was evidence of VEEV recombination between nucleotides 4800–5830 observed using
the program RDP. However, this region corresponds to the nsP3 gene, which is highly variable
with frequent insertions and deletions, even within subtypes. Aligning the insertions and dele-
tions is problematic, so this recombination result cannot be confirmed.
Selection analysis
Using SLAC, we estimated a global dN/dS ratio of 0.057, suggesting that purifying selection is
the predominant evolutionary force acting on the VEEV genome. A total of 2900 negatively
selected sites were detected using the SLAC algorithm (at p<0.1). Nonetheless, we found evi-
dence for episodic diversifying positive selection at 23 codons using MEME (at p<0.05; identi-
fied relative to their position within each protein relative to prototype VEEV strain 3880 in
Table 2). Several positively selected codons were detected in important protein genes including
the nsP4 RNA-dependent RNA polymerase, Capsid, E2 and E1 glycoproteins. However,
these sites did not include substitutions previously demonstrated experimentally to mediate
Fig 4. The genetic relationships of the IE subtype of the VEEV complex. MCC tree as determined by coalescent analysis for the IE
strains. All branches had posterior probabilities of >0.97 except for the branches marked with a *, which did not have significant support.
Time to most recent common ancestor (tMRCA) as determined by the MCC tree were added to major branches with the HPD in brackets. If
the clades were supported by BSREL the tMRCA and HPD were emboldened.
https://doi.org/10.1371/journal.pntd.0005693.g004
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adaptation for equine amplification or bridge vector infection involved in epizootic VEE emer-
gence [21, 57], underscoring the limitations of dN/dS-based selection analyses.
Discussion
VEEV continues to be a major public health problem in Latin America and understanding the
evolution and spread of this virus in the New World is integral to implementing surveillance
strategies and prevention programs. Although the genetic mechanisms of emergence of epi-
demic strains is relatively well understood [19, 20, 28, 59], the evolution of the group as a
whole has not been studied in a comprehensive manner. Using Bayesian molecular dating
techniques, we investigated the evolutionary dynamics of the VEE complex while taking into
consideration the effect of purifying selection on the accuracy of dating ancient nodes within
this group of viruses. The genomic sequencing of 94 VEEV isolates from all known endemic
countries, the inclusion of most isolates from epidemic/epizootic events, and incorporation of
the known temporal distribution of available isolates facilitated an extensive investigation into
the origin and evolutionary history of this important group of pathogens.
We estimated dates of divergence for several subtypes in the VEE complex. However, the
presence of purifying selection can bias such analyses, and our attempts to date the entire VEE
complex were limited by this bias. Analysis of ID/IAB/IC strains revealed two main lineages.
One circulates primarily in Panama, with a few Peruvian strains included. The origin of this
Table 2. Codon positions predicted to be under episodic positive selection, showing the amino acid changes and the proteins altered. Amino acid
position is defined using the Genome sequence 3908 (Accession number U55350 in the NCBI database) and numbered against the non-structural and struc-
tural polyproteins.
Protein Amino acid position (ORF) p-value Amino acid change Protein function
nsP1 3 0.021 K—> T NA
nsP1 130 0.016 T—>Q/R Viral methyltransferase
nsP1 444 0.002 N—> P/S/D NA
nsP1 487 0.049 I—> V/L NA
nsP2 884 0.007 P—> S Viral Helicase
nsP3 1344 0.045 Y—>M/I/E/S Appr -1 -p processing enzyme
nsP4 1921 0.031 S—> V/A RNA polymerase
nsP4 1991 0.043 L—> E RNA polymerase
nsP4 2162 0.014 M—> L/A RNA polymerase
nsP4 2397 <0.001 C—>S/R RNA polymerase
Capsid 10 0.014 M—> T Capsid
Capsid 66 0.007 P—> K/Q/R/S Capsid
Capsid 92 0.025 K—>G/P/Q/R/S Capsid
Capsid1 100 0.028 A—>N/T/PV/H/G Capsid
E3 303 0.006 A—> S/V E3 glycoprotein
E2 451 0.046 D—> E/G/N/K E2 glycoprotein
E2 527 0.044 G—> R E2 glycoprotein
E2 533 0.016 E—> D/K E2 glycoprotein
E2 547 0.001 T—> K/S/R/Q E2 glycoprotein
E2 647 0.003 E—> H/N/K E2 glycoprotein
E1 819 0.038 T—> S E1 glycoprotein
E1 976 0.020 A—> V E1 glycoprotein
E1 1153 0.025 K—> R E1 glycoprotein
1Protein change associated with epidemic strains of IE in 1996 and 2003 [58].
https://doi.org/10.1371/journal.pntd.0005693.t002
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group was estimated at around 102 years ago, although confidence limits were broad. From
the phylogeny we were able to infer that circulation of VEEV may have been present initially
in Panama, with a subsequent introduction into Peru. The exact mechanism of introduction
into Peru is not understood; the enzootic cycle of VEEV involves rodents and mosquitoes that
have limited geographic range, suggesting other mechanisms of transport such as birds may be
occasionally be involved in virus movement. The presence of Peruvian sequences in two dis-
tinct lineages suggests that there have been at least two independent introductions. Exclusion
of VEEV subtypes III-VI and the lack of isolates from countries intermediate between Panama
and Peru will therefore limit the possibility of fully resolving the ancestral dispersal of these
viruses.
As in previous analyses, our results confirm that the IAB strains group together with strain
Hoja Redonda, isolated in Peru in 1942, which is basal in the group. Previous partial sequenc-
ing and analysis of these strains suggested that some of the IAB outbreaks were a result of
incompletely inactivated vaccines [27]. We were able to corroborate this finding using full
genome strains that showed tight genetic distance (96.08–99.23%), and no identified ID pro-
genitors (i.e. strains that are genetically related but lack the defining E2 mutations that are
associated with the IAB subtypes), although this could be due to inaccurate sampling. How-
ever, compared to the spacing of the strains comprising the IC subtype, which are not known
to have been used for vaccine production and are interspersed throughout the phylogeny, all
the IAB strains appear to have a single origin, and previous analyses have shown that these
cluster with vaccine strains used around the time these viruses were circulating [27].
The IC subtype, which has been characterized both phylogenetically and experimentally
using reverse genetics, was determined to be a result of amino acid changes in the E2 protein
of enzootic subtype ID strains [28, 59]. The IC strains are found within 2 distinct clades in
the VEEV phylogeny, particularly in the Colombian/Venezuelan lineage. However, our data
suggest that no IC epizootic/epidemic strains have arisen from the Panamanian lineage. It is
possible that epistatic interactions limit the emergence of IC epidemic mutations from these
Panamanian ID strains, as has been described for chikungunya virus emergence [60, 61].
Despite strong experimental evidence that substitutions in the E2 protein mediate adaptation
for equine amplification or bridge vector infection involved in epizootic VEE emergence [21,
57], our sequence analyses failed to detect positive selection on the corresponding codons
(Table 2). This finding underscores the limitations of current dN/dS methods for identifying
unique adaptive substitutions occurring during virus evolution, as they typically require
repeated substitution events at a given site to detect adaptive evolution.
The IE VEEV subtype is confined to Central America and Mexico; in fact there appears to
be a demarcation between the ID subtype and the IE subtype at the Panamanian/Costa Rican
border with the exception of the BT2607 and MenalI strains isolated in western Panama in
1961 and 1962, respectively (Fig 1). More surveillance in Panama is required to determine
if these VEEV IE subtypes are still circulating. The main VEEV IE lineage is subdivided into
two clades: a widely dispersed group with strains from Guatemala, Honduras, Nicaragua and
Mexico (Pacific Coast lineage) and a group with more limited dispersal circulating mainly in
Mexico (Gulf Coast lineage). As is expected of a rodent-hosted arbovirus, there is very little
spread among countries and the dispersal within the IE subtype appears to occur between
neighboring countries, presumably reflecting the limited mobility of rodents and mosquitoes
(Fig 4). Given the limited number of countries represented in the IE phylogeny and the lack of
recent sampling in most countries, it is hard to draw further conclusions about the historical
spread of this subtype within Central America. However, recent detailed studies of VEEV cir-
culation in Mexico demonstrate geographic stability of independently evolving lineages in that
country [62].
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Previous phylogenetic analyses of the VEE complex viruses were performed using partial
and complete structural protein gene sequences [25]. Using these expanded sequences we
observed 63 synapomorphic mutations associated with the IE subtype (Group H). Of these, 39
were in the non-structural protein genes and 37 in the structural genes. This finding was sig-
nificantly different from an expected, random distribution throughout the VEEV genome. It is
possible that the preponderance of structural protein substitutions reflects adaptation to differ-
ent mosquito vectors. Subtype ID strains are vectored by at least three mosquito species: Cx.
(Melanoconion) adamesi, Cx. (Mel.) vomerifer and Cx. (Mel.) pedroi [63], whereas the subtype
IE strains appear to be more specialized and vectored nearly exclusively by Cx. (Mel.) taeniopus
[64]. Experimental infections with subtypes IAB, IC and ID have demonstrated poor infectiv-
ity at the level of midgut infection, suggesting specific subtype IE adaptation to this vector [64,
65]. Although the true distributions of Cx. taeniopus and Cx. pedroi are not completely certain
because they were not distinguished until 1980 [66], recent collection records and revisions
[63, 67–73] suggest that the former is restricted to Mexico, Central America and the Carib-
bean, while the latter occurs throughout northern South America and Central America, as well
as in Mexico. Additionally, neither Cx. vomerifer or Cx. adamesi, both subtype ID vectors, are
found north of Panama [74, 75], which may restrict the distribution of the ID subtype. Regard-
less of the original mechanism of spatial compartmentalization, between these subtypes, the IE
strains appear to have adapted specifically to Cx. taeniopus while the other subtypes remain
poorly infectious for this species [76].
In summary, our comprehensive analysis of all available full-length VEE complex genomes
demonstrated that purifying selection as a confounding factor in coalescent analyses and only
the more recently diverged subtypes could have their tMRCAs reliably estimated. Purifying
selection is an inherent determinant of arbovirus evolution because of the alternating vector-
host transmission and could therefore introduce bias into coalescent analyses of similar
viruses. By restricting this bias by analyzing only those clades for which the BSREL analysis
indicated that standard nucleotide models would not introduce severe bias we were able to
robustly estimate the tMRCA of several VEEV lineages. Evolution of the IE subtype appears to
have been characterized by a significant evolutionary shift from the rest of the VEEV complex,
with an increase in structural protein substitutions that may reflect adaptation to its mosquito
vector. Additionally our inferred tree topologies, suggest that VEEV is maintained primarily in
limited geographic foci with only occasional spread to neighboring countries, probably reflect-
ing the limited mobility of rodent hosts and mosquito vectors. Additional strains of subtypes
II-VI are needed to more completely characterize the evolution of the entire VEE complex of
alphaviruses.
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